$COCHJun 25, 2026, 12:33 PMAI processed
Envoy Medical (COCH) terminates $15M ATM equity facility
AI Summary
Envoy Medical (COCH) terminated its at-the-market equity facility that allowed the company to sell up to $15.0 million of common stock, effective June 24, 2026. The company said the move reflects confidence in its current capital position, but the release gives no cash-balance or runway details and removes a ready mechanism for near-term equity raises (i.e., potential dilution). Timing: Same-day dilution is possible only if the company starts sales under the facility, and the press release does not say when that could happen.
Positives
- Company states termination reflects confidence in current capital position
- Removes potential dilution from the previously authorized $15.0M ATM capacity
- Termination effective June 24, 2026
Negatives
- Cancels a ready, rapid equity-raising tool that could have funded near-term needs
- Press release provides no update on cash balance, runway, or alternative financing plans
- The $15.0M ATM represented a material portion of the company's ~ $49.5M market cap
Filing Context
Filing and Dilution Context
Earliest dilution
Earliest dilution: after company starts sales
Dilution status
conditional
Dilution timing
Dilution status: Undetermined
Trigger type
purchase_trigger